JACOBS LEVY EQUITY MANAGEMENT, INC – Revance Therapeutics, Inc. Transaction History
JACOBS LEVY EQUITY MANAGEMENT, INC portfolio value:
$24.79M
portfolio value
JACOBS LEVY EQUITY MANAGEMENT, INC quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1345.65% | 854.75K shares | 23.91M | $27 | 918.27K |
| Q2 2022 | share | Decrease | -4.41% | -2.93K shares | -418K | $13.82 | 63.52K |
| Q1 2022 | share | Decrease | -71.79% | -169.07K shares | -2.54M | $19.5 | 66.45K |
| Q4 2021 | share | Increase | 0.00% | 235.52K shares | 3.84M | $16.49 | 235.52K |
| Q1 2020 | share | Decrease | -100.00% | -65.17K shares | -1.05M | $14.8 | 0 |
| Q4 2019 | share | Decrease | -73.64% | -182.11K shares | -2.15M | $16.23 | 65.17K |
| Q3 2019 | share | Increase | +3.54% | 8.44K shares | 117K | $13 | 247.29K |
| Q2 2019 | share | Increase | 0.00% | 238.84K shares | 3.09M | $12.97 | 238.84K |
| Q3 2016 | share | Decrease | -100.00% | -51.4K shares | -699K | $16.21 | 0 |
| Q2 2016 | share | Decrease | -37.99% | -31.49K shares | -748K | $13.6 | 51.4K |
| Q1 2016 | share | Increase | 0.00% | 82.89K shares | 1.44M | $17.46 | 82.89K |